SmartCap Venture Capital Fund has invested €3 million in Nordic Science Investments, emphasizing the importance of bridging academic research and business through support for science-based startups in the New Nordics.

Information on the Target

SmartCap Venture Capital Fund has made a significant investment of €3 million in Nordic Science Investments (NSI), an early-stage venture capital fund dedicated to bridging the gap between academic research and commercial businesses. NSI specializes in funding science-based startups that address global challenges, with a particular focus on deeptech, health tech, and life sciences. The fund has developed strong partnerships with over 12 prominent regional universities, including Estonia’s leading institutions, underscoring its commitment to fostering innovation in the New Nordics.

Since its launch in February 2024, NSI has successfully invested in 19 pioneering companies, one of which is Estonian-based Mu-Ray Tech. These companies are at the intersection of various scientific disciplines and emerging technologies, aiming to convert cutting-edge research into scalable, competitive businesses that can thrive on a global scale. By concentrating on innovation sectors such as healthy aging, techbio, semiconductors, advanced materials, and intelligent systems, NSI positions itself at the forefront of technological advancement.

Industry Overview in the Target’s Specific Country

The startup ecosystem in Estonia is rapidly evolving, recognized for its ability to foster deep tech and health tech innovations. This small Baltic nation has emerged as a significant player in research and development, characterized by a robust network